Primary liver cancer is a common malignant tumor. China is a highrisk area for liver cancer, with approximately 55% of the liver cancer patients worldwide living in China. These studies indicate that the imbalance of liver cancer cells at the G2/M checkpoint is an important reason for the promotion of HCC.
Hepatocellular carcinoma (HCC) is a common and aggressive malignant tumor with a poorly defined molecular mechanism. Cyclin-dependent kinase 2 (CDK2) and Septin2 (SEPT2) are 2 known oncogenic molecules but the mechanism of functional interactions remains unclear. Here, we interestingly found that CDK2 and SEPT2 show very similar dynamic expression during the cell cycle. Both CDK2 and SEPT2 show the highest protein levels in the G2/M phase, resulting in CDK2 interacting with SEPT2 and stabilizing SEPT2 in HCC. In a panel of 8 pairs of fresh HCC tissues and corresponding adjacent tissues, both western blot and immunohistochemistry (IHC) assays demonstrate that CDK2 expression is highly correlated with SEPT2. HCC with high expression of both CDK2 and SEPT2 are more likely to relapse. This observation is further demonstrated by a large panel of 100 HCC patients. In this large panel, high expression of both CDK2 and SEPT2 significantly correlates with tumor differentiation and microvascular invasion, which is an independent prognostic factor in HCC patients. In summary, our results reveal a cooperative function between CDK2 and SEPT2. HCC with high expression of CDK2 and SEPT2 might be more aggressive and respond poorly to current therapy.
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Cyclin-dependent kinases (CDKs) are essential to the cell cycle regulatory network, which is mainly regulated by cyclin and other proteins. 7 CDK2, an important member of the CDK family that regulates the G1/S and G2/M checkpoints, mainly changes the activity of the substrate by directly phosphorylating the serine/threonine residues on the substrate, resulting in the promotion of cell cycle progression. 8 Abnormally activated CDK2 can simultaneously cause abnormalities in G1/S and G2/M checkpoints and play an important role in tumor cell hyperproliferation. 9 At present, the regulation mechanism of CDK2 on G1/S checkpoint is very clear. However, the specific regulation mechanism of the G2/M checkpoint has not been fully clarified. 8 Therefore, exploring the mechanism of CDK2 on the G2/M checkpoint is of great significance for the diagnosis and treatment of HCC.
Septin2 is one of the conserved filamentous guanosine triphosphatases (GTPases), and has different effects in cell cycles.
In interphase cells, SEPT2 are associated with actin stress fibers.
However, in dividing cells, SEPT2 are associated with the contractile ring. 10 In addition, SEPT2 plays an important role in the formation of spindles and the separation of sister chromatids by regulating the polymerization and separation of tubulin, thereby regulating G2/M phase transition and cell mitosis. 11 Therefore, these findings guide us to continuously explore the mechanism of CDK2 and SEPT2 in promoting the G2/M phase transition, which promotes the development of liver cancer. 
| E XPERIMENTAL PROCEDURE S

| Western blot and immunoprecipitation analyses
| Preparation of stable expression cell lines
SMMC-7721 cells were transfected with the plasmids and then screened by 1 μg/mL of puromycin (ApexBio, Houston, TX, USA), and stable expression cell lines were obtained.
| Cell synchronization
For the double thymidine block, 1 × 10 6 cells were seeded on 10-cm dishes; 2 mmol/L thymidine (Sigma, Milwaukee, WI, USA) was added for 15 hours. Cells were washed with PBS and released into growth medium for 9 hours. Cells were cultured in 2 mmol/L thymidine again for 15 hours, washed, and released into growth medium. 
| Cell proliferation assays and colony formation assays
| Flow cytometry
Cells were fixed with 70% ethanol at −20°C overnight and washed 3 times using cold PBS. The samples were stained with PI/RNase Staining Buffer (BD Pharmingen, Franklin Lakes, NJ, USA) for 15 minutes at room temperature according to the manufacturer's instructions. Stained cells were analyzed with a BD FACSCanto II Flow
Cytometer. The results were analyzed by ModFit LT 3.1.
| Xenograft mouse model
Nude mice were obtained from Nantong University Laboratory
Animal Center. SMMC-7721 cell suspension in DMEM (5 × 10 6 / mouse) was subcutaneously injected into male nude mice. Mice were killed at 10 weeks after implantation, and tumor xenografts were collected.
| Patients and tissue samples and immunohistochemistry analyses
Hepatocellular carcinoma tissues were obtained from 100 patients with HCC who underwent hepatic surgical resection without preoperative systemic chemotherapy in the Affiliated Hospital of Nantong University (Nantong, China). Tissue samples were immediately pro- The evaluation criteria of immunohistochemistry staining were as follows: staining intensity was scored as 0 (negative), 1 (weak), 2 (medium) and 3 (strong). Extent of staining was scored as 0 (0%), 1 (1%-25%), 2 (26%-50%), 3 (51%-75%) and 4 (76%-100%)
according to the percentages of the positive staining areas in relation to the whole carcinoma area. The sum of the intensity and extent score was used as the final staining score (0-7) for CDK2
and SEPT2. Tumors with a final staining score of ≥3 were considered positive.
| Statistical analyses
Cumulative survival time was calculated using the Kaplan-Meier method, and differences were compared by log-rank test. Univariate and multivariate analyses were based on the Cox proportional hazards regression model. The χ 2 test, Fisher's exact probability and Student's t test were used for comparison between groups.
Statistical significance was defined by a P-value <.05. Statistical analyses were performed using the Statistical Program for Social Sciences v20 software (SPSS Inc., Chicago, IL, USA).
| RE SULTS
| Correlated dynamic expression of cyclindependent kinase 2 and Septin2 during cell cycle
Studies have suggested that NEDD5 (SEPT2) is not only expressed in all brain tumors but also changes with the cell cycle progression, reaching a peak in the G2/M phase. 12 However, It is well known that different CDK play distinct roles in different tumor cell cycles. For the first time, we discovered through a serum starvation experiment that CDK2 was consistent with the trend of SEPT2 from the early G1 phase ( Figure 1A) . Subsequently, the expression of CDK2
and SEPT2 in different cell cycles was analyzed using the double thymidine synchronization method. We found that protein abundance of SEPT2 and CDK2 fluctuated during cell cycles in HCC cell lines, peaking in G2/M phase, followed by a sharp reduction in early G1 phase ( Figure 1B ).
| Cyclin-dependent kinase 2 activates Erk pathway by stabilizing Septin2
Cyclin-dependent kinases play crucial roles in regulating the stability of cell cycle-related proteins during cell cycle progression. 15, 16 We constructed corresponding knockdown stable cell lines ( Figure 2A ). Knockdown CDK2 in SMMC-7721 decreased the expression of SEPT2 ( Figure 2B ). In previous research, SEPT2 was shown to promote tumor development by activating the Erk signaling pathway in breast cancer and glioblastoma. 17, 18 Therefore, we explored whether CDK2 activated the Erk signaling pathway by stabilizing SEPT2. Consistent with our conjecture, the results
showed that the declined expression of SEPT2 after knockdown of CDK2 was accompanied by the decrease of p-Erk protein expression without affecting the total Erk expression ( Figure 2B ).
The above results indicate that CDK2 can stabilize SEPT2, thereby promoting the development of HCC by activating the Erk signaling pathway.
| Cyclin-dependent kinase 2 promotes hepatocellular carcinoma cell proliferation by regulating Septin2
Previous studies have shown that SEPT2 can promote tumor progression, enhancing the cell invasion ability. 17, 19 According to our study, cell viability was decreased after CDK2 knockdown, and then restored after overexpressing SEPT2 ( Figure 2C ). Similarly, knockdown of CDK2 inhibited the ability of HCC cell clone formation, which was restored after overexpressing SEPT2 ( Figure 2D ). 
| Cyclin-dependent kinase 2 interacts with Septin2 without phosphorylation
Early studies showed that CDK2, belonging to a CDK that phosphorylates downstream substrates, promotes chromatin instability and tumor development. 20 In the present study, we demonstrated an endogenous interaction between CDK2 and SEPT2 ( Figure 3A , top) and other exogenous interactions ( Figure 3A, bottom) . Further immunofluorescence experiments also revealed that CDK2 and SEPT2 are colocalization in the cytoplasm ( Figure 3B ). Previously, our experiments also demonstrated that the protein abundance of CDK2 and SEPT2 fluctuated with the progression of the cell cycle and peaked in the G2/M phase. Under the same conditions, we further found that in the G2/M phase, the interaction intensity between the CDK2 and SEPT2 was also greater than that of the G1/S phase ( Figure 3C ). These results revealed the interaction of CDK2 and SEPT2 in SMMC-7721 cells. Some scholars have demonstrated that CDK has significant kinase function by recognizing the T/S-P-x-K/R residue on the substrate. 21, 22 Interestingly, when we analyzed the amino acid sequence of SEPT2 we found no such residues. In experiments, we also confirmed that even if CDK2 is overexpressed, there are no phosphorylated threonine and serine residues of SEPT2 ( Figure 3D ).
| Cyclin-dependent kinase 2 promotes the tumorigenicity of HCC cells by regulating Septin2
Our data demonstrate that CDK2 could interact with SEPT2 and promote HCC cell proliferation. Next, we injected the corresponding stable cell line into nude mice and found that the tumorigenicity of HCC cells significantly decreased. CDK2 expression was very low as a result of CDK2 knockdown, and the tumor volume and quality were dramatically decreased. After re-expressing SEPT2, the tumorigenicity increased, and the volume and quality also increased ( Figure 4A -C).
| Cyclin-dependent kinase 2 and Septin2 co-express in hepatocellular carcinoma and promote recurrence
Next, we further explored protein abundance of CDK2 and SEPT2
in HCC tissues. We selected 8 pairs of fresh HCC tissues and corresponding adjacent tissues. It is worth noting that protein abundance of CDK2 and SEPT2 in tumor tissues was significantly higher than that of corresponding adjacent tissues ( Figure 5A ), which was consistent with IHC staining results ( Figure 5B ). We subsequently collected tumors and adjacent tissues from 100 patients with HCC, and statistically analyzed the pathological sections after IHC staining.
Further analysis of these cases revealed that the time to recurrence of the CDK2/SEPT2 double positive group was significantly higher than that of others ( Figure 5C ).
| High expression of cyclin-dependent kinase 2 and Septin2 is an independent prognostic factor
We explored the correlation of CDK2/SEPT2 and clinical pathological parameters. The data, as shown as in Table 1 , demonstrated that the expression of CDK2/SEPT2 was significantly associated with histological grade (P < .001) and microvascular invasion (P = .013).
The results of univariate analysis and multivariate analysis, which are summarized in Table 1 , showed that HBV-DNA, tumor size, number of nodules, microvascular invasion and a patient being CDK2/SEPT2 double positive were prognostic factors of recurrence; among them, HBV-DNA and a patient being CDK2/SEPT2 double positive were also considered to be independent prognostic factors for recurrence.
| D ISCUSS I ON
Clinical treatment of HCC is still based on traditional methods, such as surgical resection and chemotherapy. Although these methods can improve the prognosis of patients, the effects are unsatisfactory.
In addition, multi-kinase inhibitors (sorafenib and regorafenib) and immunology checkpoint inhibitors (nivolumab and lipilimumab) are available, and the latter can dramatically improve clinical outcomes.
Therefore, it is of great significance to explore better adjuvant treatment strategies for improving the prognosis of patients with HCC. 23, 24 Cell cycle disorder is a major feature of cancer cells, result- Previous studies have suggested that the Septin family is associated with a variety of human tumors. 27 Studies have also analyzed the expression of the Septin gene in 35 human tumors, and found that septin 2, 8, 9 and 11 are significantly upregulated, while Septin4 and 10 are the opposite. In summary, SEPT2 may be a cancerpromoting gene; however, knowledge of the mechanism is still limited. 28 It is noteworthy that NEDD5 (SEPT2) is not only expressed in all brain tumors but also changes with the cell cycle progression. 12 In this study, we found that the protein abundance of CDK2 and SEPT2 fluctuated with the cell cycle progression consistently, and all reached a peak in the G2/M phase. It has been confirmed that the CDK2/cyclin E complex can phosphorylate p27 in G1 to cause ubiquitin-mediated degradation of p27, resulting in G1/S phase transition. 29, 30 However, the mechanism by which CDK2 regulates G2/M phase conversion is not well understood. In this study, we attempted to clarify that CDK2 promotes G2/M detection point conversion by
stabilizing SEPT2.
Our study demonstrated that CDK2 interacted with SEPT2 and activated the Erk signaling pathway, and the interaction between CDK2 and SEPT2 also peaked in G2/M phase. We also verified that the above mechanism was verified in vivo trials.
Finally, in fresh tumor tissues, western blot and IHC also demonstrated that CDK2 expression was highly correlated with SEPT2 and was significantly higher than that of paraneoplastic tissues. Data from 100 paraffin samples of HCC patients further supported the above results and revealed that high expression of CDK2 and SEPT2 was closely related to tumor differentiation and microvascular invasion, and could be an independent prognostic factor in HCC patient.
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